Emily Tharp
Neurology · Houston, TXNPI 1063970341
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for neurology clinicians in TX, where the typical reported total is $2,170.
Across 80 payments — averaging $33.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$542
- Acadia Pharmaceuticals Inc$400
- Neurocrine Biosciences, Inc.$320
- Amneal Pharmaceuticals LLC$218
- Abbott$160
- Novartis$157
- plus $866 from 18 others
What the payments were for
- Food & beverage$2,662100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $542 |
| Acadia Pharmaceuticals Inc | 10 | $400 |
| Neurocrine Biosciences, Inc. | 7 | $320 |
| Amneal Pharmaceuticals LLC | 5 | $218 |
| Abbott | 1 | $160 |
| Novartis | 7 | $157 |
| Argenx US, Inc. | 2 | $153 |
| UCB, Inc. | 5 | $120 |
| Teva Pharmaceuticals USA, Inc. | 3 | $106 |
| Eisai Inc. | 3 | $80 |
| Merz Pharmaceuticals, LLC | 2 | $67 |
| Genentech USA, Inc. | 2 | $47 |
| Biogen | 2 | $42 |
| CSL Behring | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Sanofi | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $18 |
| AstraZeneca | 1 | $17 |
| Pfizer | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$243
- INFINITY$160
- VYVGART HYTRULO$124
How this compares
$2,662 in reported general payments places this provider in the 50th percentile of 1,246 neurology providers in Texas.
Other neurology in Houston
- William OndoHouston$1.4M
- Pankaj SatijaHouston$1.1M
- Annette HowardHouston$826K
- Randolph EvansHouston$493K
- Leorah FreemanHouston$401K
- Mazen DimachkieHouston$388K
- Zsila SadighiHouston$361K
- Joseph JankovicHouston$323K
- Raja MehannaHouston$300K
- Eddie PattonHouston$299K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.